Health ❯ Chronic Diseases ❯ Diabetes

Obesity

Hypertension Dietary Interventions Dementia Cardiovascular Diseases GLP-1 Receptor Agonists Public Health Implications Smoking Sarcopenia Treatment Options GLP-1 Medications Semaglutide-Based Therapies Neurodevelopmental Disorders Cardiometabolic Benefits Breast Cancer Medication Development Health Outcomes Weight Management Inflammation GLP-1 Agonists Treatment Protocols Drug Treatments Dietary Impact Kidney Transplants Lifestyle Factors Health Risks Treatment Innovations Impact of Meal Timing Cardiovascular Risk Risk Factors Heart Failure GLP-1 Treatments Dietary Changes Healthcare Access Weight Loss Drugs

RSNA Study Links Muscle Mass, Lower Visceral Fat to Younger 'Brain Age'

Findings from 1,164 MRI scans suggest a body composition marker that could guide future dementia‑risk trials.

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

Metformin Linked to Lower Dementia and Mortality Risks in Overweight, Obese Adults

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study